NL192325B - Aqueous nasal pharmaceutical composition containing dehydroergotamine and spray delivery device. - Google Patents

Aqueous nasal pharmaceutical composition containing dehydroergotamine and spray delivery device.

Info

Publication number
NL192325B
NL192325B NL8300325A NL8300325A NL192325B NL 192325 B NL192325 B NL 192325B NL 8300325 A NL8300325 A NL 8300325A NL 8300325 A NL8300325 A NL 8300325A NL 192325 B NL192325 B NL 192325B
Authority
NL
Netherlands
Prior art keywords
dehydroergotamine
pharmaceutical composition
composition containing
delivery device
spray delivery
Prior art date
Application number
NL8300325A
Other languages
Dutch (nl)
Other versions
NL8300325A (en
NL192325C (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NL8300325A publication Critical patent/NL8300325A/en
Publication of NL192325B publication Critical patent/NL192325B/en
Application granted granted Critical
Publication of NL192325C publication Critical patent/NL192325C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL8300325A 1982-02-01 1983-01-28 Aqueous nasal pharmaceutical composition containing dehydroergotamine and spray delivery device. NL192325C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01
GB8202781 1982-02-01

Publications (3)

Publication Number Publication Date
NL8300325A NL8300325A (en) 1983-09-01
NL192325B true NL192325B (en) 1997-02-03
NL192325C NL192325C (en) 1997-06-04

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8300325A NL192325C (en) 1982-02-01 1983-01-28 Aqueous nasal pharmaceutical composition containing dehydroergotamine and spray delivery device.

Country Status (27)

Country Link
JP (1) JPS58134017A (en)
AT (1) AT385656B (en)
AU (1) AU565613B2 (en)
BE (1) BE895750A (en)
CA (1) CA1197783A (en)
CH (1) CH653555A5 (en)
DE (1) DE3302949A1 (en)
DK (1) DK164771C (en)
ES (1) ES519450A0 (en)
FI (1) FI81258C (en)
FR (1) FR2539994B1 (en)
GR (1) GR81320B (en)
HK (1) HK59989A (en)
HU (1) HU191512B (en)
IE (1) IE54532B1 (en)
IL (1) IL67822A (en)
IT (1) IT1197558B (en)
KE (1) KE3888A (en)
LU (1) LU84613A1 (en)
MY (1) MY8700766A (en)
NL (1) NL192325C (en)
NZ (1) NZ203117A (en)
PH (1) PH22198A (en)
PT (1) PT76166B (en)
SE (1) SE454402B (en)
SG (1) SG34389G (en)
ZA (1) ZA83673B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
EP4147699A1 (en) * 2018-01-05 2023-03-15 Impel Pharmaceuticals Inc. Intranasal delivery of dihydroergotamine by precision olfactory device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (en) * 1976-11-19 1978-06-01 Sandoz Ag NEW FORMS OF ADMINISTRATION FOR ORGANIC COMPOUNDS
FR2387035A1 (en) * 1977-04-12 1978-11-10 Cassenne Lab Sa NEW MEDICINAL PRODUCT INTENDED IN PARTICULAR FOR THE TREATMENT OF FUNCTIONAL CEREBRAL DISORDERS
DE2831728C2 (en) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Medicines used to treat headaches

Also Published As

Publication number Publication date
BE895750A (en) 1983-08-01
ES8502865A1 (en) 1985-02-01
DK164771B (en) 1992-08-17
SE454402B (en) 1988-05-02
IE830187L (en) 1983-08-01
SE8300495D0 (en) 1983-01-31
PT76166B (en) 1986-02-04
ATA30383A (en) 1987-10-15
PH22198A (en) 1988-06-28
PT76166A (en) 1983-02-01
MY8700766A (en) 1987-12-31
IL67822A0 (en) 1983-06-15
IE54532B1 (en) 1989-11-08
HU191512B (en) 1987-02-27
ES519450A0 (en) 1985-02-01
NL8300325A (en) 1983-09-01
CA1197783A (en) 1985-12-10
SG34389G (en) 1989-09-22
FI830245A0 (en) 1983-01-25
GR81320B (en) 1984-12-11
FI81258C (en) 1990-10-10
FI830245L (en) 1983-08-02
SE8300495L (en) 1983-08-02
ZA83673B (en) 1984-09-26
DK38183A (en) 1983-08-02
FR2539994B1 (en) 1986-10-10
IT1197558B (en) 1988-12-06
AT385656B (en) 1988-05-10
IT8347646A0 (en) 1983-02-01
HK59989A (en) 1989-08-04
FR2539994A1 (en) 1984-08-03
NZ203117A (en) 1986-12-05
DK38183D0 (en) 1983-01-31
JPS58134017A (en) 1983-08-10
LU84613A1 (en) 1983-09-08
DE3302949A1 (en) 1983-08-11
IL67822A (en) 1988-02-29
AU565613B2 (en) 1987-09-24
DK164771C (en) 1992-12-28
DE3302949C2 (en) 1992-05-21
NL192325C (en) 1997-06-04
CH653555A5 (en) 1986-01-15
KE3888A (en) 1989-09-01
FI81258B (en) 1990-06-29
JPH0253406B2 (en) 1990-11-16
AU1085083A (en) 1983-08-11

Similar Documents

Publication Publication Date Title
MX9203263A (en) ANALGESICAL PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION.
NO822371L (en) Dose inhaler.
NO851881L (en) DEVICE FOR THE DELIVERY OF VOCABLE, ACTIVE MATERIALS.
DE69105609D1 (en) Packaging for microdoses of powdered medication for inhalation.
GB2100605B (en) Bandage for administering drugs.
IT8548421A0 (en) AEROSOL TYPE DISPENSING DEVICE, PARTICULARLY FOR MEDICINES
DE3875025D1 (en) COMPOSITION CONTAINING CALCITONIN FOR NASAL ADMINISTRATION.
PH16812A (en) Amino acid derivatives,agent containing these compounds,and the use thereof
PT88404A (en) DOSAGE FORM COMPRISING FAST AGENT DELIVERY FOLLOWED BY SLOW AGENT DELIVERY
IT8821065A0 (en) DEVICE FOR INHALING DOSED AEROSOLS.
NO152644C (en) DELIVERY DEVICE FOR PASFORMED PRODUCTS.
NO803685L (en) MEDICAL DISPENSER (INHALATOR).
IT7923092V0 (en) CONTAINER FOR TWO TYPES OF DOSING UNITS IN PARTICULAR FOR THE TREATMENT OF THE RESPIRATORY TRACT.
IT8619625A0 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION.
IT1209380B (en) SPRAYER FOR POWDERED SUBSTANCES.
NL190237C (en) AMINO ETHERS AND MEDICINAL PRODUCT CONTAINING THESE AMINO ETHERS.
NO162056C (en) MEDICAL DELIVERY DEVICE.
NO153129C (en) DELIVERY VALVE AND DEVICE.
BE894175A (en) NEW IMIDAZOTETRAZINONES, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THEM.
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
NL194300B (en) Pharmaceutical composition containing a polyprenol as an active ingredient and polyprenols suitable for use therein.
NL191307C (en) Analgesically active piperazine derivatives and pharmaceutical preparations containing these derivatives.
DE3581704D1 (en) MEDICINE DISPENSING SYSTEM.
NO863625D0 (en) DRUG DOSAGE DEVICE.
NL192325B (en) Aqueous nasal pharmaceutical composition containing dehydroergotamine and spray delivery device.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
SNR Assignments of patents or rights arising from examined patent applications

Owner name: NOVARTIS AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20030128